The Staphylococcus pseudintermedius group (SIG) is an emerging threat in veterinary medicine, particularly methicillin-resistant (MRSP) isolates, which are frequently associated with multidrug resistance. Reliable identification of SIG members is critical to establish correct antimicrobial treatments. However, information on the molecular epidemiology and antimicrobial resistance patterns of MRSP in some regions is still limited. This study aimed to assess the antimicrobial resistance of SIG isolates recovered from animals at the Veterinary Teaching Hospital of Complutense University of Madrid (Spain) during a 10-year period (2007–2016). A total of 139 selected Staphylococcus isolates were subjected to species-level identification by different bioanalytical techniques (PCR, VITEK, MALDI-TOF) and subsequent antimicrobial susceptibility testing. Methicillin-resistant isolates (n = 20) were subjected to whole genome sequencing for further characterization of their antibiotic resistance determinants. Our results showed that there was a good correlation between PCR and MALDI-TOF identification, whereas VITEK showed very divergent results, thus confirming MALDI-TOF as a good alternative for species-level identification of coagulase-positive staphylococci. Notably, S. pseudintermedius, including the epidemic MRSP genotype ST71, was the only SIG species found among canine isolates. In addition, we found a high prevalence of multidrug resistance and resistance to fluoroquinolones, cephalosporins and macrolides. Finally, diverse genes associated with antibiotic resistance were detected among MRSP isolates, although the genetic basis of some of the resistant phenotypes (particularly to fluoroquinolones) could not be determined. In conclusion, our study reveals the circulation of MRSP in the veterinary setting in Spain, thus highlighting the emerging threat posed by this bacterial group and the need for further epidemiological surveillance.

Acinetobacter is one of the most relevant pathogenic and nosocomial bacterial genus in human medicine. However, in veterinary medicine, and especially in Spain, there are very few studies about the impact and frequency of infections due to this genus. The main objective of this study was to characterise Acinetobacter isolates analysed at the Complutense Veterinary Teaching Hospital of the Complutense University of Madrid, with special emphasis on detecting antimicrobial resistance. A total of 23 isolates obtained from different animal species and samples over a 27-year period, were included in the study. Identification was made by using MALDITOF, VITEK-2, whole-genome sequencing and a chromogenic medium. Antimicrobial susceptibility was interpreted according to CLSI guidelines using the Kirby-Bauer disk diffusion and broth microdilution method. The proportion of clinical isolates identified as Acinetobacter spp. at the HCV-UCM was 0.3%. The frequency of AMR was low, though 30.8% of the isolates were classified as multidrug-resistant. Two isolates with the highest MIC for temocillin carried the tet(X) gene, and two isolates had mutations in both gyrA and parC QRDR regions. The results of this study suggest that, in Spain, antimicrobial resistance in Acinetobacter isolates of veterinary origin might not be yet widespread.

A canine population’s immune resistance to canine distemper virus (CDV), canine parvovirus (CPV), and infectious hepatitis virus (CAV-1) was evaluated. In this study, a total of 112 sera were analyzed. Animals were considered as vaccinated if, in the last two years, they had re-ceived at least one dose of a vaccine that provides joint protection against CDV, CPV, and CAV-1. Animals that had never received any dose of these vaccines were designated as non-vaccinated. CDV, CPV, and CAV-1 antibodies were detected via a modified solid-phase enzyme-linked im-munosorbent assay (ELISA), which detects IgG antibody levels in sera and provides semi-quantitative results in less than 30 min. In total, 41.1% of the dogs had been vaccinated, and 58.9% of dogs were designated as non-vaccinated. Overall, 90.2%, 92.0%, and 78.6% of the tested dogs had positive results for the presence of IgG antibodies against CPV, CDV, and CAV-1, re-spectively. CPV antibodies were present in 93.5% (43/46) of the vaccinated and 87.9% (58/66) of the non-vaccinated dogs, while CDV antibodies were present in 95.5% (63/66) of the vaccinated and 87.0% (40/46) of the non-vaccinated dogs. Finally, CAV-1 antibodies were present in 84.8% (56/66) of the vaccinated and of 69.6% (32/46) the non-vaccinated dogs.

Acinetobacter is one of the most relevant pathogenic and nosocomial bacteria in human medicine. However, in veterinary medicine, particularly in Spain, there are very few studies on the impact and frequency of infections due to this genus. The main objective of this study was to characterise Acinetobacter isolates recovered at the Complutense Veterinary Teaching Hospital of the Complutense University of Madrid (HCV-UCM), with special emphasis on detecting antimicrobial resistance. A total of 23 isolates obtained from different animal species and samples over a 25-year period were included in the study, based on their identification as Acinetobacter by VITEK-2. Identification was made by using MALDI-TOF, VITEK-2, whole-genome sequencing (WGS) and a chromogenic medium. WGS confirmed that 13 of the 23 isolates belonged to Acinetobacter spp. Antimicrobial susceptibility was interpreted according to CLSI guidelines using the Kirby–Bauer disk diffusion and broth microdilution method. The proportion of clinical isolates identified as Acinetobacter spp. at the HCV-UCM was 0.3%. Of these, 15.4% (2/13 isolates) were classified as multidrug-resistant. Two isolates with the highest MIC for tigecycline carried the tet(X) gene, and two isolates harboured mutations in both gyrA and parC QRDR regions. The results of this study suggest that, in this hospital, antimicrobial resistance among Acinetobacter isolates may not yet be widespread.